GSK, Yale partner to develop new drugs targeting disease-causing proteins

GlaxoSmithKline (NYSE:GSK) hopes to develop a new class of medicines through a new drug discovery partnership with Yale University. The collaboration will build on Yale’s research into ways to b…
Read the full story: MedCity News